Skip to content

Available 24/7 for Urgent On-Site or Virtual Consulting

  • (208) 971-6430
  • [email protected]

FDA Inspections

Consulting and Compliance

  • Industries
    • Biologics
    • Cosmetics
    • Dietary Supplements
    • Medical Devices
    • Pet Food and Animal Health
    • Pharmaceuticals
  • Services
    • FDA 483 Response Consulting
    • FDA Inspection Facilitation Services
    • FDA Inspection Readiness Services
    • FDA Inspection Training
    • FDA Warning Letter Remediation
    • Mock FDA Inspections and Gap Assessment Services
    • Virtual FDA Inspection Consulting
  • Resources
  • News
  • Industries
    • Biologics
    • Cosmetics
    • Dietary Supplements
    • Medical Devices
    • Pet Food and Animal Health
    • Pharmaceuticals
  • Services
    • FDA 483 Response Consulting
    • FDA Inspection Facilitation Services
    • FDA Inspection Readiness Services
    • FDA Inspection Training
    • FDA Warning Letter Remediation
    • Mock FDA Inspections and Gap Assessment Services
    • Virtual FDA Inspection Consulting
  • Resources
  • News
Contact Us

The United States and European Union will be able to use each other’s Pharmaceutical Inspections

  • May 26, 2025
You need to be logged in to view this content. Please Log In. Not a Member? Join Us
PrevPreviousHome
NextUS FDA Issues Warning Letter to Lucky Pacific Corp and Kamli International Co. Ltd.Next

Latest News and Articles

A validation inspector wearing blue nitrile gloves calibrating an industrial pressure gauge connected to reinforced single-use processing tubes inside a cleanroom.
What Happens During an FDA For-Cause Inspection?
A logistics inspector in gray utility gloves writing on a clipboard to check a shipping manifest and temperature logs at a global container port terminal.
FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect
A regulatory auditor in gray utility gloves using a rugged mobile tablet to review electronic system audit trails and digital quality data networks inside a pharmaceutical lab.
How FDA Uses AI and Data Analytics During Modern Inspections
A pharmaceutical quality auditor wearing blue nitrile safety gloves executing a surface validation swab on the inner rim of an open stainless steel blending vessel.
The Most Common FDA 483 Observations in Pharmaceutical Manufacturing
A heavy-duty stainless steel chromatography column base connected to clear braided transfer tubes containing clear amber biological harvest fluid within a sterile facility.
How FDA Inspects Viral Vector Manufacturing Facilities
A cleanroom validation technician using a torque wrench to adjust a mechanical valve on an industrial chromatography column unit within a biopharmaceutical plant.
FDA Pre-Approval Inspections (PAIs) for Biologics: Common Readiness Gaps
A corporate compliance director holding a transparent digital glass tablet to cross-reference automated data logs and live facility monitoring streams.
FDA Remote Regulatory Assessments (RRAs): What Biotech Companies Need to Know
A regulatory affairs director and a clinical operator reviewing automated data lineage paths on an interactive luminescent glass panel inside a pharmaceutical facility.
How FDA Investigators Review Batch Records During Drug Inspections
A bioprocess engineer in a full sterile cleanroom suit inspecting single-use bioreactor tubing lines and electronic validation graphs during an mRNA manufacturing facility audit.
How FDA Inspects mRNA and Advanced Therapy Manufacturing Facilities
A corporate regulatory compliance director analyzing global manufacturing data and remote assessment metrics on a transparent digital glass tablet in a high-tech tracking hub.
FDA Inspection Trends in 2026: Biologics, AI, Foreign Facilities, and Remote Assessments

FDA Inspections

Your trusted partner for FDA compliance and inspection readiness. With former ex-FDA’ers  on our team, we provide the expertise and confidence you need to succeed.

  • (208) 971-6430
  • [email protected]

Services

  • Pre-Inspection Prep
  • On-Site Support
  • CAPA Development
  • Staff Training
  • Documentation
  • Emergency Support

Industries

  • Pharmaceuticals
  • Medical Devices
  • Biotechnology
  • Food & Beverage
  • Cosmetics
  • Clinical Research
© 2024 FDA Inspections. All rights reserved.
  • Privacy Policy
  • Terms of Service
  • Disclaimer
THE IMMERSIVE FDA INSPECTION EXPERIENCE →
WARNING LETTERS 483 OBSERVATIONS